Gut Microbiome and Radioiodine-Refractory Papillary Thyroid Carcinoma Pathophysiology.
Gut Microbiome and Radioiodine-Refractory Papillary Thyroid Carcinoma Pathophysiology.
Trends Endocrinol Metab. 2020 Apr 06;:
Authors: Samimi H, Haghpanah V
Abstract
Gut microbiome (GM) might be associated with radioiodine (RAI)-refractory papillary thyroid carcinoma (PTC) through different mechanisms related to sodium/iodide (Na+/I-) symporter (NIS) regulation. However, whether thyroid carcinoma (TC), especially RAI-refractory PTC, causes dysbiosis, or vice versa, is still unknown. Further studies are needed to investigate the mechanism between GM and RAI-refractory PTC.
PMID: 32273149 [PubMed - as supplied by publisher]
Source: Trends in Endocrinology and Metabolism: TEM - Category: Endocrinology Authors: Samimi H, Haghpanah V Tags: Trends Endocrinol Metab Source Type: research
More News: Cancer & Oncology | Carcinoma | Endocrinology | Sodium | Study | Thyroid | Thyroid Cancer